Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
An early work, presented in 1995 by Dentico and colleagues, evaluated the effect of 30-day administration of high doses of intravenous or intramuscular GSH on liver cytolysis indexes in patients with chronic steatosic liver disease ( A subsequent study of Irie and colleagues in 2016 showed that the use of oral glutathione, at a daily dosage of 300 milligrams per day, may prevent NASH progression from NAFLD ( The study by Honda et al., conducted in 2017, was an open-label, single-arm, multicentre pilot study that evaluated the therapeutic effect of oral glutathione administration (300 mg/day) in patients with NAFLD through the evolution of biochemical indices (ALT) and liver fat levels assessed by VCTE ( These preliminary studies suggest a potential therapeutic effect of oral administration of GSH in NAFLD
Discuss your preferences with your prescribing clinician, who can provide guidance tailored to your circumstances and help you establish a sustainable administration schedule
May 11, 2026 4 min read Anti-Aging What Does Research Indicate About GHK-Cus Protective Effects in COPD or Lung Fibrosis
Does BPC-157 Really Work
US$ 21.65
US$ 28.18
US$ 22.19
US$ 22.98
US$ 23.59
